News
"ALA-CART improves the ability of CAR-T cells to detect and attack resistant cancer cells more effectively. This could lead to longer lasting results, even when other treatments have failed," said ...
In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with Parkinson’s disease and observed promising motor improvements with no ...
Hosted on MSN2mon
Japan's iPS Cell Breakthroughs Are Reshaping Regenerative ... - MSNPerhaps the most promising use for iPS cells is in the treatment of Parkinson’s disease, a neurodegenerative condition due to the death of dopamine-secreting neurons in the brain.
Induced Pluripotent Stem Cell (iPSC) Industry Trends & Forecasts 2025-2030: From Disease Modeling to Cell Therapy - iPSCs Emerge as Cornerstone of Precision Healthcare - ResearchAndMarkets.com ...
“This trial showed that iPS cell–derived dopaminergic neurons are safe, produce dopamine in the brain, and ameliorate neurological symptoms. I think it is a significant first step,” study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results